Skip to content
★ Sign in to follow
BH

Brenton Hanlon

Abaxis Inc
Total declarations
84
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (68 ops.)
€901k

Latest filing published 23 Aug 2012 for ABAXIS INC, €3,087.

Insider track record

Disclosed buys
0
Disclosed sells
68
Signal history

No signal scores available.

Brenton Hanlon: trading record in brief

All filings by Brenton Hanlon on record concern Abaxis Inc. We count 84 filings; the first trade dates from 28 April 2006 and the latest from 22 August 2012.

The open-market record consists of 68 sales worth €901k, with no purchase. Other entries cover 1 share grant and 15 option exercises. Since January 2012: no purchases and 27 sales on the market.

The newest entry dates from 23 August 2012: an open-market sale of €3,087, in Abaxis Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Brenton Hanlon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations71 total
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,870 USD0SEC
    100 shares@ US$38.70Common StockSEC:0001140361-12-038332:0
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    972 USD0SEC
    25 shares@ US$38.86Common StockSEC:0001140361-12-038332:1
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,890 USD0SEC
    100 shares@ US$38.90Common StockSEC:0001140361-12-038332:2
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,881 USD0SEC
    100 shares@ US$38.81Common StockSEC:0001140361-12-038332:3
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,875 USD0SEC
    100 shares@ US$38.75Common StockSEC:0001140361-12-038332:4
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,886 USD0SEC
    100 shares@ US$38.86Common StockSEC:0001140361-12-038332:7
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,893 USD0SEC
    100 shares@ US$38.93Common StockSEC:0001140361-12-038332:8
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    619 USD0SEC
    16 shares@ US$38.70Common StockSEC:0001140361-12-038332:9
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    11,610 USD0SEC
    300 shares@ US$38.70Common StockSEC:0001140361-12-038332:15
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    621 USD0SEC
    16 shares@ US$38.80Common StockSEC:0001140361-12-038332:16
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,892 USD0SEC
    100 shares@ US$38.92Common StockSEC:0001140361-12-038332:19
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    3,880 USD0SEC
    100 shares@ US$38.80Common StockSEC:0001140361-12-038332:20
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    620 USD0SEC
    16 shares@ US$38.75Common StockSEC:0001140361-12-038332:21
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    20,395 USD0SEC
    527 shares@ US$38.70Common StockSEC:0001140361-12-038332:26
  • ◇
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    0SEC
    1,000 shares0Common StockSEC:0001140361-12-023146:0
  • ◇
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    0SEC
    2,000 shares0Common StockSEC:0001140361-12-023146:1
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    60,523 USD0SEC
    2,160 shares@ US$28.02Common StockSEC:0001140361-11-056595:0
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    21,667 USD0SEC
    773 shares@ US$28.03Common StockSEC:0001140361-11-056595:1
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    2,806 USD0SEC
    100 shares@ US$28.06Common StockSEC:0001140361-11-056595:2
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    2,802 USD0SEC
    100 shares@ US$28.02Common StockSEC:0001140361-11-056595:3
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    56,040 USD0SEC
    2,000 shares@ US$28.02Common StockSEC:0001140361-11-056595:4
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    72,384 USD0SEC
    2,600 shares@ US$27.84Common StockSEC:0001140361-11-056087:0
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    8,352 USD0SEC
    300 shares@ US$27.84Common StockSEC:0001140361-11-056087:1
  • ◇
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    0SEC
    2,000 shares0Common StockSEC:0001140361-11-051269:0
  • ▼
    VP-Sales & Marketing,MedicalExecutivesAbaxis Inc
    11,324 USD0SEC
    400 shares@ US$28.31Common StockSEC:0001140361-11-031702:0

25 of 71 declarations